Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Remepy forms partnership with Merck KGaA to develop Hybrid Drugs and secure $36 million in funding.

Aug 13, 2026•1 day ago

Contract Type

partnership

Ramat GanBiotechnology

Description

Remepy has raised $36 million in Series A funding to advance its drug-software combination treatments. The funding will help expand its pharmaceutical co-development partnerships and support a Phase III trial of its lead program for Parkinson's disease in collaboration with Merck KGaA.

Company Information

Company

Remepy

Location

Ramat Gan, Tel Aviv District, Israel

About

Remepy is an Israeli startup that specializes in developing hybrid drugs combining traditional drugs with 'digital molecules' to enhance their effectiveness.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Remepy's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.